Cargando…
A robust classifier of high predictive value to identify good prognosis patients in ER-negative breast cancer
INTRODUCTION: Patients with primary operable oestrogen receptor (ER) negative (-) breast cancer account for about 30% of all cases and generally have a worse prognosis than ER-positive (+) patients. Nevertheless, a significant proportion of ER- cases have favourable outcomes and could potentially be...
Autores principales: | Teschendorff, Andrew E, Caldas, Carlos |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2008
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2575547/ https://www.ncbi.nlm.nih.gov/pubmed/18755024 http://dx.doi.org/10.1186/bcr2138 |
Ejemplares similares
-
An immune response gene expression module identifies a good prognosis subtype in estrogen receptor negative breast cancer
por: Teschendorff, Andrew E, et al.
Publicado: (2007) -
A consensus prognostic gene expression classifier for ER positive breast cancer
por: Teschendorff, Andrew E, et al.
Publicado: (2006) -
High-resolution aCGH and expression profiling identifies a novel genomic subtype of ER negative breast cancer
por: Chin, Suet F, et al.
Publicado: (2007) -
The breast cancer somatic 'muta-ome': tackling the complexity
por: Teschendorff, Andrew E, et al.
Publicado: (2009) -
Prognostic gene network modules in breast cancer hold promise
por: Teschendorff, Andrew E, et al.
Publicado: (2010)